Document is current
Any future updates will be listed below
-
Authors
Fitzek, Mira P.
Boucherie, Deirdre M.
de Vries, Tessa
Handtmann, Cleo
Fathi, Haniyeh
Raffaelli, Bianca
MaassenVanDenBrink, Antoinette
-
Funding
Funding for this research was provided by:
Dutch Research Council (09150181910040)
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 8 December 2024
First Online: 3 January 2025
Declarations
:
: Not applicable.
: Not applicable.
: DMB received personal fees as speaker from Teva. MF reports personal fees from Teva. TdV received personal fees as speaker from Teva. BR reports research grants from Novartis and personal fees from Abbvie/Allergan, Eli Lilly, Hormosan, Novartis, and Teva. AMvdB received personal fees (fees as advisor or speaker, consultancy, any other) from Allergan-Abbvie, Lilly, Novartis and Teva. She received research support from Novartis, Satsuma and Tonix, as well as independent research support from the Dutch Research Council and the Netherlands Organisation for Health Research and Development.
